16368167|t|Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
16368167|a|Beta-amyloid (Abeta) peptide has been proposed to be a causal factor in Alzheimer's disease (AD). Currently being investigated, active and passive Abeta-immunotherapy significantly reduce Abeta plaque deposition, neuritic dystrophy, and astrogliosis in the brains of APP transgenic (APP/Tg) mice. Immunization with Abeta42 formulated in the Th1-type adjuvant QS21 was beneficial for AD patients with significant titers of anti-Abeta antibodies, however, 6% of participants developed meningoencephalitis, likely due to anti-Abeta-specific autoimmune Th1 cells. Thus, successful Abeta vaccination requires the development of strong antibody responses without Th1-type cellular immunity. In this study, we compared the induction of humoral immune responses with Th1-type (Quil A) and Th2-type (Alum) adjuvants singly and in combination, using our novel epitope vaccine composed of self B cell epitope Abeta(1-15) and foreign T cell epitope PADRE (PADRE-Abeta(1-15)-MAP). Formulated in Quil A, this vaccine resulted in significantly higher anti-Abeta antibody responses in both BALB/c (H-2d) and C57BL/6 (H-2b) mice, compared with Alum. Anti-Abeta antibodies induced by Alum were predominantly IgG1 type accompanied by lower levels of IgG2a and IgG2b. Quil A induced robust and almost equal titers of anti-Abeta antibodies of IgG1 and IgG2a isotypes and slightly lower levels of IgG2b. Switching adjuvants from Alum to Quil A induced higher concentrations of antibodies than injections with Alum only, however slightly lower than Quil A only. Switching both adjuvants did not change the profile of antibody responses generated by the initial adjuvant injected. These results suggest that switching from Alum to Quil A would be beneficial for AD patients because anti-Abeta antibody production was enhanced without changing the initially generated and likely beneficial Th2-type humoral response.
16368167	10	29	Alzheimer's disease	Disease	MESH:D000544
16368167	75	80	Abeta	Gene	351
16368167	104	108	Alum	Chemical	MESH:C041524
16368167	112	118	Quil A	Chemical	MESH:C046386
16368167	150	155	Abeta	Gene	351
16368167	208	227	Alzheimer's disease	Disease	MESH:D000544
16368167	229	231	AD	Disease	MESH:D000544
16368167	283	288	Abeta	Gene	11820
16368167	324	329	Abeta	Gene	11820
16368167	349	367	neuritic dystrophy	Disease	MESH:D058225
16368167	373	385	astrogliosis	Disease	MESH:D005911
16368167	427	431	mice	Species	10090
16368167	451	458	Abeta42	Gene	351
16368167	495	499	QS21	Chemical	MESH:C078785
16368167	519	521	AD	Disease	MESH:D000544
16368167	522	530	patients	Species	9606
16368167	563	568	Abeta	Gene	351
16368167	619	638	meningoencephalitis	Disease	MESH:D008590
16368167	659	664	Abeta	Gene	351
16368167	713	718	Abeta	Gene	351
16368167	905	911	Quil A	Chemical	MESH:C046386
16368167	927	931	Alum	Chemical	MESH:C041524
16368167	1118	1124	Quil A	Chemical	MESH:C046386
16368167	1177	1182	Abeta	Gene	11820
16368167	1228	1235	C57BL/6	CellLine	CVCL:C0MU
16368167	1243	1247	mice	Species	10090
16368167	1263	1267	Alum	Chemical	MESH:C041524
16368167	1274	1279	Abeta	Gene	351
16368167	1302	1306	Alum	Chemical	MESH:C041524
16368167	1326	1330	IgG1	Gene	105243590
16368167	1367	1372	IgG2a	Gene	668478
16368167	1377	1382	IgG2b	Gene	16016
16368167	1384	1390	Quil A	Chemical	MESH:C046386
16368167	1438	1443	Abeta	Gene	351
16368167	1458	1462	IgG1	Gene	105243590
16368167	1467	1472	IgG2a	Gene	668478
16368167	1511	1516	IgG2b	Gene	16016
16368167	1543	1547	Alum	Chemical	MESH:C041524
16368167	1551	1557	Quil A	Chemical	MESH:C046386
16368167	1623	1627	Alum	Chemical	MESH:C041524
16368167	1662	1668	Quil A	Chemical	MESH:C046386
16368167	1835	1839	Alum	Chemical	MESH:C041524
16368167	1843	1849	Quil A	Chemical	MESH:C046386
16368167	1874	1876	AD	Disease	MESH:D000544
16368167	1877	1885	patients	Species	9606
16368167	1899	1904	Abeta	Gene	351
16368167	Negative_Correlation	MESH:D005911	11820
16368167	Negative_Correlation	MESH:C078785	MESH:D000544
16368167	Negative_Correlation	11820	16016
16368167	Negative_Correlation	MESH:D000544	11820
16368167	Negative_Correlation	MESH:C041524	11820
16368167	Negative_Correlation	MESH:C041524	MESH:D000544
16368167	Negative_Correlation	11820	351
16368167	Negative_Correlation	MESH:C041524	16016
16368167	Negative_Correlation	11820	668478
16368167	Negative_Correlation	MESH:C046386	351
16368167	Negative_Correlation	105243590	11820
16368167	Negative_Correlation	MESH:C078785	11820
16368167	Association	MESH:D008590	351
16368167	Association	MESH:D058225	11820
16368167	Comparison	MESH:C041524	MESH:C046386
16368167	Negative_Correlation	MESH:C046386	11820
16368167	Negative_Correlation	MESH:C046386	16016
16368167	Negative_Correlation	MESH:C078785	351
16368167	Negative_Correlation	MESH:C046386	MESH:D000544
16368167	Negative_Correlation	MESH:C041524	668478
16368167	Association	MESH:D000544	351
16368167	Association	105243590	351
16368167	Negative_Correlation	MESH:C041524	351

